# Odyssey Therapeutics, Inc.: Form SCHEDULE 13D, filed May 15, 2026

- Company: [Odyssey Therapeutics, Inc.](/companies/odtx.md) (CIK 1882782)
- Form: SCHEDULE 13D
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 14:58 ET
- Period: not reported
- Accession: 0000950103-26-007273
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1882782/000095010326007273/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1882782/000095010326007273/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1882782/000095010326007273/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0000950103-26-007273. Last ingested by Listed: Nov 4, 2026, 07:35 ET. No prices; not investment advice.